Quantcast
Last updated on April 18, 2014 at 17:24 EDT

Latest Heavy metal Stories

2013-06-18 08:30:28

CARLSBAD, Calif., June 18, 2013 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS), the leader in antisense therapeutics, today announced that management will present a general corporate update in conjunction with its 2013 Annual Meeting of Stockholders and Open House on Tuesday, June 25 at 2:10 p.m. Pacific Time in Carlsbad, CA. The agenda for the meeting is as follows:2:00 p.m. - 2:10 p.m. Annual Meeting of Stockholders (only for stockholders of record as of April 26, 2013)2:10 p.m....

2013-06-06 08:28:56

CARLSBAD, Calif., June 6, 2013 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announced today that it has earned a $6 million payment from AstraZeneca related to continuation of the research collaboration between Isis and AstraZeneca to discover and develop novel antisense therapeutics to treat cancer. In addition to the research collaboration, which includes three cancer targets, Isis and AstraZeneca are developing two antisense drugs, ISIS-AR(Rx) and ISIS-STAT3(Rx), discovered...

2013-06-05 08:28:01

CARLSBAD, Calif., June 5, 2013 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS), the leader in antisense therapeutics, today announced that management will present a company overview at the Goldman Sachs 34(th) Annual Global Healthcare Conference on Wednesday, June 12, 2013 at 1:20 p.m. PT in Rancho Palos Verdes, CA. A live audio webcast of the presentation will be available on the "Investors & Media" section of the Company's Web site, www.isispharm.com. A replay will be...

2013-05-31 16:24:03

CARLSBAD, Calif., May 31, 2013 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announced today that the underwriters of its previously announced public offering of common stock, which was completed on May 14, 2013, have exercised their option to purchase an additional 617,869 shares of Isis' common stock. The closing of the sale of the additional shares is expected to take place on June 4, 2013, subject to customary closing conditions. Including the 9,000,000 shares of common...

2013-05-23 12:24:16

Season 12 Premieres Saturday, June 1st at 11:00 PM ET/PT With New Look, New Segments and Same Great Hosts NEW YORK, May 23, 2013 /PRNewswire/ -- It's time to get metaled up. VH1 Classic's centerpiece in original programming, "That Metal Show" is returning for its 12(th) season. The acclaimed hard rock and heavy metal talk show hosted by Eddie Trunk, Don Jamieson, and Jim Florentine kicks off the latest season on Saturday, June 1(st) at 11:00PM ET/PT. "That Metal Show" is back...

2013-05-23 08:27:01

CARLSBAD, Calif., May 23, 2013 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS), the leader in antisense therapeutics, today announced that management will present a company overview at the Deutsche Bank 38(th) Annual dbAccess Health Care Conference on Thursday, May 30, 2013 at 8:40 a.m. ET in Boston, MA. A live audio webcast of the presentation will be available on the "Investors & Media" section of the Company's Web site, www.isispharm.com. A replay will be available on the...

2013-05-15 23:29:42

OHK Medical Devices Ltd., manufacturer of the HemaClear® single-use, sterile, exsanguinating tourniquet device, announced today that it will hold its first annual Italian distributor and user conference; May 22, 2013 in Rome, Italy. Haifa, Israel (PRWEB) May 15, 2013 OHK Medical Devices Ltd., manufacturer of the HemaClear® single-use, sterile exsanguinating tourniquet device, announced today that it will hold its first annual Italian distributor and user conference; May 22, 2013 in...

2013-05-13 08:28:17

CARLSBAD, Calif., May 13, 2013 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS), the leader in antisense therapeutics, today announced that management will present a company overview at the 2013 UBS Global Healthcare Conference on Monday, May 20, 2013 at 9:00 a.m. ET in New York, NY. A live audio webcast of the presentation will be available on the "Investors & Media" section of the Company's Web site, www.isispharm.com. A replay will be available on the Isis Web site...

2013-05-09 00:20:49

CARLSBAD, Calif., May 8, 2013 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announced today the pricing of an underwritten public offering of 9,000,000 shares of its common stock, offered at a price to the public of $19.00 per share. The gross proceeds to Isis from this offering are expected to be $171.0 million, before deducting the underwriting discount and other estimated offering expenses payable by Isis. The offering is expected to close on or about May 14, 2013, subject to...

2013-05-08 12:26:43

Magisto's Mother's Day challenge seeks to turn everyday family videos and photos into a creative tribute to mom and launches new song from Osborne NEW YORK, May 8, 2013 /PRNewswire/ -- Magisto has teamed up with multi-platinum selling recording artist and seven-time Grammy nominee Joan Osborne to celebrate Mother's Day with a new form of music discovery that brings together powerful user-generated video production technology and musical artistry. Joan's new song "Born To See You...


Latest Heavy metal Reference Libraries

Brilliant Emerald, Somatochlora metallica
2013-07-30 14:54:37

The brilliant emerald (Somatochlora metallica) is a species of dragonfly that can be found in northern areas of Eurasia. Its range includes Austria, Belgium, Croatia, Denmark, France, Germany, Norway, Serbia, Sweden, and the United Kingdom, among many other areas. This species prefers to reside near still and slow-moving water sources like rivers, canals, ponds, and moorland lakes. It is common in most areas of its range, but its total population number and population trend is unknown. It is...

More Articles (1 articles) »